Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586806 | SCV000696654 | uncertain significance | not provided | 2017-03-06 | criteria provided, single submitter | clinical testing | Variant summary: The AIRE c.589G>A (p.Gly197Arg) variant located in the SAND domain (via InterPro) involves the alteration of a non-conserved nucleotide, which 3/4 in silico tools (SNPs&GO not captured due to low reliability index) predict a damaging outcome, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 13/120306 (1/9250), predominantly in the African cohort, 11/10266 (1/933), which does not exceed the estimated maximal expected allele frequency for a pathogenic AIRE variant of 1/357. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories. Therefore, until additional information becomes available (ie, clinical and functional studies), the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)." |
Labcorp Genetics |
RCV001834836 | SCV003292336 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834836 | SCV002083862 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-02-19 | no assertion criteria provided | clinical testing |